EuroBio
Eurobio Scientific Acquires EndoPredict, Licenses Prolaris ex-US from Myriad Genetics
Myriad retained the rights to produce and sell EndoPredict in the US as part of its Precise Oncology Solutions platform.
UK's NICE Expands Tumor Profiling Recommendations for Guiding Adjuvant Chemo in Early Breast Cancer
Previously, NICE recommended EndoPredict, Prosigna, and Oncotype DX for node-negative breast cancer only, but the new guidance includes lymph node-positive disease.
Myriad Genetics Reorganizes European Operations, Sells EndoPredict Business to Eurobio Scientific
The company said the deal is expected to close later this year, after which it will still license the rights to produce and sell EndoPredict within the US.